Picture of Sangamo Therapeutics logo

SGMOQ Sangamo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Sangamo Therapeutics Says It Determined Not To Award Annual Cash Bonus, With Respect To 2023 Co Performance, To Co's Executive Officers, Including CEO, CFO

Jan 19 (Reuters) - Sangamo Therapeutics Inc  SGMO.O :
    * SANGAMO THERAPEUTICS: DETERMINED NOT TO AWARD ANNUAL CASH
BONUS,
WITH RESPECT TO 2023 CO PERFORMANCE, TO CO'S EXECUTIVE OFFICERS,
INCLUDING CEO, CFO

Further company coverage:  SGMO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sangamo Therapeutics

See all news